DiscoverToxChats©Changing Approaches to Getting Drug Candidates into First-in-Human Clinical Trials: A Case Study
Changing Approaches to Getting Drug Candidates into First-in-Human Clinical Trials: A Case Study

Changing Approaches to Getting Drug Candidates into First-in-Human Clinical Trials: A Case Study

Update: 2024-12-18
Share

Description

Not every drug that has reached human clinical trials has needed preliminary nonclinical studies to demonstrate safety. This podcast episode is a case study for replacing the use of animals during the safety testing that occurs prior to human clinical trials, in which our guest speaker reviews conversations with regulatory authorities regarding a modern nonanimal testing strategy utilized to bring a nonequine-derived antitoxin as a therapeutic product to a patient.
Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Changing Approaches to Getting Drug Candidates into First-in-Human Clinical Trials: A Case Study

Changing Approaches to Getting Drug Candidates into First-in-Human Clinical Trials: A Case Study

ACT ToxChats